Alan Parsa, MD
Endocrinology, Diabetes & Metabolism · Honolulu, HINPI 1215268362
Payments from drug & device makers
Across 1,520 payments — averaging $2701.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Eli Lilly$3.2M
- Dexcom, Inc.$157K
- AbbVie$149K
- Lilly USA, LLC$137K
- Novo Nordisk$136K
- Corcept Therapeutics$101K
- plus $264K from 25 others
Across 12 payments — averaging $15,475 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$186K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Eli Lilly | 110 | $3,162,388 |
| Dexcom, Inc. | 29 | $157,134 |
| AbbVie | 15 | $149,062 |
| Lilly USA, LLC | 250 | $136,767 |
| Novo Nordisk | 271 | $136,029 |
| Corcept Therapeutics | 91 | $101,180 |
| Bayer | 80 | $90,953 |
| Boehringer Ingelheim | 258 | $88,133 |
| AstraZeneca | 123 | $37,614 |
| Abbott | 94 | $37,139 |
| Amgen(2 entities) | 64 | $7,561 |
| Sanofi-aventis U.S. LLC | 40 | $702 |
| Radius Health, Inc. | 18 | $436 |
| Insulet Corporation | 23 | $387 |
| Tandem Diabetes Care, Inc. | 6 | $342 |
| Merck | 20 | $246 |
| Amarin Pharma, Inc. | 6 | $189 |
| Amryt Pharma Holdings Ltd | 3 | $181 |
| Neurocrine Biosciences, Inc. | 1 | $160 |
| Johnson & Johnson | 3 | $50 |
| Insmed, Inc. | 1 | $50 |
| Xeris Pharmaceuticals, Inc. | 2 | $49 |
| Bioventus LLC | 2 | $41 |
| Senseonics, Incorporated | 1 | $41 |
| Recordati_rare_diseases_inc. | 2 | $38 |
| Medtronic | 2 | $38 |
| Averitas Pharma Inc. | 1 | $36 |
| Mannkind Corporation | 1 | $26 |
| Melinta Therapeutics, LLC | 1 | $19 |
| Vistapharm, Inc. | 1 | $15 |
| Smith+Nephew | 1 | $13 |
How this compares
$4,107,021 in reported general payments places this provider in the 95th percentile of 22 endocrinology, diabetes & metabolism providers in Hawaii.
See all endocrinology, diabetes & metabolism providers in Hawaii →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other endocrinology, diabetes & metabolism in Honolulu
- Cindy PauHonolulu$8.2M
- Kelsey Shikuma LeeHonolulu$19K
- Anna Melissa LoHonolulu$13K
- Lisa WongHonolulu$12K
- Eric LeeHonolulu$3K
- Isabel CasimiroHonolulu$2K
- Se Mo SuhHonolulu$2K
- Chanhaeng RheeHonolulu$2K
- Kamonkiat WirunsawanyaHonolulu$1K
- Jennifer LohHonolulu$890
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.